News

Bladder cancer survivor Irene Price and Dr. David Nanus

2017 Apr 05

Evolving therapeutic strategies in renal cell carcinoma

David Nanus, M.D., discusses evolving therapeutic strategies in the neoadjuvant and adjuvant setting for patients with RCC at the 2017 Interdisciplinary Prostate Cancer Congress. Read more

Manish Shah, M.D., gastrointestinal oncology expert at the Meyer Cancer Center of Weill Cornell Medicine

2017 Apr 05

Long-term aspirin may cut risk for cancer death

Manish Shah, M.D., comments on a study about the association of long-term aspirin use and cancer death. Read more

A group of people together posing for a photo

2017 Apr 03

Investigators Named to Stand Up 2 Cancer’s Colorectal Dream Team

Weill Cornell Medicine and NewYork-Presbyterian have been named to the nonprofit Stand Up 2 Cancer’s Colorectal Dream Team to drive new advances in colorectal cancer research and treatment. The interdisciplinary team, funded... Read more

Lew Cantley and Katie Couric at Stand Up to Cancer/AACR announcement event

2017 Apr 03

Weill Cornell Medicine joins colorectal cancer 'Dream Team'

A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers. Read more

2017 Apr 02

Bringing bladder cancer into focus

Bishoy Faltas, M.D., and LaMont Barlow, M.D., are exploring FAK inhibition as a potential targeted therapy for urothelial cancer. Read more

2017 Apr 02

Cell therapy provides shot at a cure for fatal thyroid cancer

In the first demonstration of the potential for CAR-T therapy for previously untreatable advanced thyroid cancers, researchers from the Meyer Cancer Center were able to eliminate cancerous cells in cultures and mice. Read more

2017 Apr 01

Women with healthy BMI may have increased risk of breast cancer

Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to Andrew Dannenberg, M.D. Read more

2017 Apr 01

Toxic targets: Saving lives in silico

A computational tool created by graduate students predicts how people’s livers, hearts and other tissues might respond to different drugs, in order to ID potentially dangerous side effects before the drugs are tested in people. Read more

2017 Mar 31

Shedding a light on "dark matter" data

Ekta Khurana, Ph. D., assistant professor of computational genomics has created a computational tool that can mine terabytes of overlooked genomic data to uncover potentially unknown drivers of cancer. Read more

2017 Mar 30

Health conditions that disproportionately affect black women

Adrienne Phillips, M.D., discusses some cancers and blood disorders that are prevalent in black women. Read more

2017 Mar 23

Study to focus on breast cancer link to bone metastasis

Ithaca associate Claudia Fischbach-Teschl, Ph.D., has secured more than $1 million in funding from the Human Frontier Science Program (HFSP) to study breast cancer’s effect on the mineralization pathways in bone. Read more

2017 Mar 22

Why Trump’s N.I.H. cuts should worry us

A substantial N.I.H. budget cut would undermine the fiscal stability of universities and medical schools, many of which depend on N.I.H. funding; it would erode America’s leadership in medical research; and it would diminish opportunities to discover new ways to prevent and treat diseases, argues Harold Varmus, M.D. Read more